JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miura, K.
Right arrow Articles by Yamamoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miura, K.
Right arrow Articles by Yamamoto, K.

Hypotensive action of angiotensin I converting enzyme inhibitor (SQ 14,225) in nephrectomized dogs

K Miura, Y Abe and K Yamamoto

The present experiment was designed to clarify the contribution of the renin-angiotensin system to the acute depressor action of angiotensin I converting enzyme inhibitor and also to assess the role of the kidney under such conditions. In anesthetized dogs, intrarenal and i.v. infusion of SQ 14,225 at a rate of 0.5 mg/min resulted in a significant and similar fall in systemic blood pressure. This effect was not altered even when the receptors were occupied by exogenous angiotensin II (100 ng/min i.v.) This would suggest that the renin-angiotensin system plays a relatively minor role in the blood pressure reduction in normotensive anesthetized dogs. Six hours after nephrectomy when the plasma renin activity had become negligible, SQ 14, 225 produced a significant fall in systemic blood pressure. The magnitude was not statistically different from that noted during i.v. infusion of SQ 14,225 in the dog with both kidneys intact. The effect was abolished after inhibition of kallikrein, as induced by aprotinin (10,000 kallikrein inhibitory unit/kg i.v., 10,000 kallikrein inhibitory unit/kg.hr i.v.). In light of these findings, the possibility that the extrarenal kallikreinkinin system contributes to the acute hypotensive action of SQ 14,225 rather than to the inhibition of the metabolism of angiotensin has to be given attention.

Volume 222, Issue 1, pp. 246-250, 07/01/1982
Copyright © 1982 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1982 by the American Society for Pharmacology and Experimental Therapeutics.